for patients affected by several different cancers tremendously improved during
the last years. New drugs, surgery, imaging and prevention contributed to
transform cancer in a curable disease.
Even so, there is large space for improvements particularly when the neoplastic lesion is identified in a later stage and surgery is not an option. For these patients, chemotherapy is often the only option available and the prognosis is unfavorable.
One of the reason for chemotherapy failure is the variability of tumors between patients and sometimes, even in the same patients cancer cells acquire different mutations.
With the precision oncology, we aim to develop protocols for reliable, fast and affordable screening to support the clinician for choosing the most effective therapy based on scientific evidences and to adapt in real time to the changing needs of a patient during the therapy.